Post Date: October 27, 2021
The first human clinical trial of FLASH therapy, a new method of proton therapy for cancer, reached an important milestone in October 2021.
Enrollment is complete for FAST-01 (FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases), according to a news release from Varian, the manufacturer of the system that delivers the therapy.
The FAST-01 trial is being led by John Breneman, MD, principal investigator, and Medical Director of the Cincinnati Children’s/UC Health Proton Therapy Center.
The $120 million Proton Therapy Center, located at Cincinnati Children’s Liberty Township campus, marked its five-year anniversary in October.
The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, diagnosis, or treatment.